XML 40 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Reverse Merger - Allocation of Total Purchase Price (Details) - Synta Pharmaceuticals Corp
$ in Thousands
Jul. 22, 2016
USD ($)
Allocation of the total purchase price to the acquired assets and liabilities assumed  
Cash, cash equivalents and marketable securities $ 42,611
Prepaid expenses and other currents assets 1,715
Property and equipment, net 482
Accounts payable, accrued expenses and other liabilities (7,019)
Term loans and capital lease obligations (18)
In-process research and development 150
Goodwill 315
Net assets acquired $ 38,236